IP Library Granted Patent US 9,504,659
Granted Patent B2
US 9,504,659 · App. 11/621,860 · Granted Nov 29, 2016

Thermoreversible oil-in-water emulsion

Inventors: Marie-Françoise Klucker (Caluire et Cuire, FR); Jean Haensler (Pollionnay, FR); Patricia Probeck-Quelleec (Lyons, FR); Pascal Chaux (Bully, FR)
Assignee: Sanofi Pasteur SA
A61K31/00A61K9/107A61K31/047A61K31/66A61K39/12A61K39/145A61K39/39A61K45/06A61K2039/55505A61K2039/55511A61K2039/55566A61K2039/70C12N2710/16134C12N2760/16134C12N2760/16234
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,504,659
App. No.
11/621,860
Granted
Nov 29, 2016
Kind
B2
Abstract

The invention relates to a thermoreversible oil-in-water emulsion comprising: a TLR4 agonist, the chemical structure of which does not comprise a sugar ring, squalene, a nonionic surfactant belonging to the polyoxyethylene alkyl ether chemical group, a hydrophilic surfactant, an aqueous solvent, and which shows immunostimulating properties.

Claims (13)

1. An Oil-in-Water (O/W) emulsion comprising,

i) a TLR4 agonist, called TLR4, the chemical structure of which does not comprise a sugar ring,

ii) squalene,

iii) an aqueous solvent,

iv) a nonionic hydrophilic surfactant which is a polyoxyethylene alkyl ether, and

v) a nonionic hydrophobic surfactant,

in which the TLR4 agonist is the chemical compound ER804057, the nonionic hydrophilic surfactant is ceteareth-12, the nonionic hydrophobic surfactant is sorbitan monooleate and the aqueous solvent is a phosphate buffer or a citrate buffer, and wherein the emulsion is thermoreversible.

2. The emulsion as claimed in claim 1 , in which:

a) the amount of squalene in the emulsion is between 5% and 45% of the total weight of the emulsion,

b) the ratio of the amount of squalene to the total amount of ceteareth-12 and of sorbitan monooleate is between 2.0 and 4.0,

c) the amounts of ceteareth-12 and of sorbitan monooleate are such that the HLB is between 8.5 and 10, and

d) the ratio of the amount of ER 804057 to the total amount of ceteareth-12 and of sorbitan monooleate is between 0.01×10 −2 and 2×10 −2 .

3. The emulsion as claimed in claim 2 , further comprising mannitol in which the amount is between 0.1 and 10% of the total weight of the emulsion.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 8, 2007
From: KLUCKER, MARIE-FRANCOISE; HAENSLER, JEAN; PROBECK-QUELLEEC, PATRICIA; CHAUX, PASCAL
To: SANOFI PASTEUR SA
Reel/Frame 018867/0396 →
Priority Claims (1)
FR 06 00309 · Jan 13, 2006 · national
Continuity (2)
Provisional Application 60780159 · Mar 8, 2006
Related Publication 20070191314A1 · Aug 16, 2007